Profile data is unavailable for this security.
About the company
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.
- Revenue in INR (TTM)13.05bn
- Net income in INR2.49bn
- Incorporated1995
- Employees2.34k
- LocationPoly Medicure LtdPlot No.104-105 & 115-116 , Sector-59,HSIDC Industrial Area, Ballabgarh,FARIDABAD 121004IndiaIND
- Phone+91 1 292307000
- Fax+91 1 292307007
- Websitehttps://www.polymedicure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Microport EP MedTech Co Ltd | 4.22bn | 220.90m | 138.29bn | 577.00 | 625.95 | 7.10 | -- | 32.79 | 0.0408 | 0.0408 | 0.7782 | 3.59 | 0.2013 | 1.18 | 9.01 | 634,687.40 | 1.05 | -- | 1.11 | -- | 61.35 | -- | 5.24 | -- | 12.39 | -- | 0.014 | -- | 26.46 | -- | 85.17 | -- | -- | -- |
| Angelalign Technology Inc | 17.00bn | 615.95m | 140.37bn | 2.88k | 227.23 | 3.65 | 91.03 | 8.26 | 0.3419 | 0.3419 | 9.44 | 21.32 | 0.3194 | 5.33 | 16.70 | 552,442.90 | 1.05 | 5.76 | 1.29 | 7.59 | 62.38 | 64.33 | 3.30 | 13.98 | 4.12 | -- | 0.0188 | -- | 16.24 | 24.75 | -74.99 | -2.20 | 20.54 | -- |
| Shenzhen YHLO Biotech Co Ltd | 21.01bn | 3.91bn | 156.93bn | 1.76k | 40.26 | 5.19 | -- | 7.47 | 0.5956 | 0.5956 | 3.21 | 4.62 | 0.4798 | 1.11 | 4.91 | 1,037,196.00 | 7.03 | 16.43 | 9.12 | 24.16 | 62.14 | 53.26 | 14.66 | 20.01 | 1.50 | -- | 0.1872 | 30.28 | -48.42 | 23.02 | -64.93 | 56.32 | 28.88 | -- |
| Micro-Tech Nanjing Co Ltd | 28.57bn | 6.08bn | 157.17bn | 2.40k | 25.83 | 3.66 | -- | 5.50 | 2.81 | 2.81 | 13.23 | 19.86 | 0.5948 | 1.62 | 6.91 | 1,032,216.00 | 12.91 | 10.74 | 14.98 | 12.82 | 64.81 | 63.04 | 21.71 | 19.37 | 5.19 | -- | 0.01 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| Shanghai MicroPort MedBot Group Co Ltd | 1.20bn | -11.66bn | 157.58bn | 650.00 | -- | 26.33 | -- | 130.80 | -1.14 | -1.14 | 0.1177 | 0.5848 | 0.0623 | 0.3746 | 42.10 | 173,636.80 | -60.96 | -- | -86.19 | -- | 14.05 | -- | -978.59 | -- | 0.8238 | -11.04 | 0.5427 | -- | 384.16 | -- | 11.20 | -- | -- | -- |
| Poly Medicure Ltd. | 13.05bn | 2.49bn | 161.57bn | 2.34k | 65.00 | -- | 51.91 | 12.38 | 25.90 | 25.90 | 135.86 | -- | -- | -- | -- | 5,577,489.00 | -- | 12.23 | -- | 15.06 | 65.03 | 55.45 | 19.06 | 15.11 | -- | 36.95 | -- | 17.98 | 20.82 | 16.41 | 22.37 | 20.49 | 23.75 | 8.45 |
| Shanghai Haohai Biological Technology | 30.35bn | 4.79bn | 167.20bn | 2.16k | 16.08 | 1.16 | 23.79 | 5.51 | 2.63 | 2.63 | 16.67 | 36.49 | 0.3765 | 1.55 | 7.50 | 1,317,562.00 | 5.89 | 4.84 | 6.86 | 5.50 | 70.34 | 72.09 | 15.65 | 16.50 | 4.50 | -- | 0.0635 | 36.86 | 25.27 | 11.26 | 130.58 | 0.0762 | 11.96 | 14.27 |
| Hartalega Holdings Berhad | 32.11bn | -5.67bn | 175.46bn | 7.56k | -- | 2.14 | -- | 5.46 | -0.0943 | -0.0943 | 0.5341 | 1.36 | 0.3316 | -- | 10.54 | 241,379.70 | -5.95 | 28.94 | -6.42 | 34.00 | -- | 46.86 | -17.94 | 29.87 | 4.84 | -37.13 | 0.0226 | 46.64 | -69.45 | 0.0331 | -107.27 | -- | 3.11 | -- |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 14.51bn | 6.35bn | 177.58bn | 908.00 | 25.51 | 3.81 | -- | 12.24 | 7.31 | 7.31 | 16.80 | 48.87 | 0.3769 | 1.60 | 7.96 | 1,387,329.00 | 16.35 | 17.68 | 18.12 | 19.43 | 75.61 | 76.60 | 43.39 | 42.25 | 9.49 | -- | 0.008 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Eyebright Medical Tchnlgy Beijing Co Ltd | 12.34bn | 3.78bn | 180.28bn | 2.07k | 47.75 | 7.07 | -- | 14.61 | 3.12 | 3.12 | 10.16 | 21.05 | 0.4003 | 1.99 | 5.19 | 516,774.60 | 11.51 | 9.99 | 13.27 | 11.16 | 72.24 | 81.29 | 28.74 | 34.66 | 2.48 | -- | 0.1339 | 19.91 | 64.14 | 49.59 | 30.63 | 71.80 | 38.83 | -- |
| Holder | Shares | % Held |
|---|---|---|
| UTI Asset Management Co. Ltd. (Investment Management)as of 31 Mar 2024 | 2.56m | 2.66% |
| Capital Research & Management Co. (World Investors)as of 31 Mar 2024 | 2.16m | 2.26% |
| quant Money Managers Ltd.as of 31 Mar 2024 | 2.04m | 2.12% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 1.59m | 1.65% |
| Matthews International Capital Management LLCas of 05 Apr 2024 | 863.62k | 0.90% |
| Kotak Mahindra Life Insurance Co., Ltd.as of 31 Mar 2024 | 609.55k | 0.64% |
| White Oak Capital Partners Pte Ltd.as of 30 Jun 2023 | 596.79k | 0.62% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 580.49k | 0.61% |
| WhiteOak Capital Asset Management Ltd.as of 31 Mar 2024 | 288.35k | 0.30% |
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 219.66k | 0.23% |
